# FDA Inspection 916765 - Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank - March 06, 2015

Source: https://www.keypedia.com/records/fda_inspections/department-af-81st-med-groupsgqc-keesler-afb-mc-blood-bank/a5dde924-c08a-4833-9c1a-1ab6fb1b1e37
Source feed: FDA_Inspections

> FDA Inspection 916765 for Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank on March 06, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 916765
- Company Name: Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank
- Inspection Date: 2015-03-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1251708 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/department-af-81st-med-groupsgqc-keesler-afb-mc-blood-bank/ab23c5e1-3efe-4638-a69d-892bd5cdac63)
- [FDA Inspection 1251708 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/department-af-81st-med-groupsgqc-keesler-afb-mc-blood-bank/6fd0f113-9192-4eda-a836-40d2c529a4e1)
- [FDA Inspection 1021631 - 2017-08-08](https://www.keypedia.com/records/fda_inspections/department-af-81st-med-groupsgqc-keesler-afb-mc-blood-bank/79b6f259-68b9-44dd-be52-f4523a6b15a3)
- [FDA Inspection 815251 - 2013-01-23](https://www.keypedia.com/records/fda_inspections/department-af-81st-med-groupsgqc-keesler-afb-mc-blood-bank/0ca1a43c-8c50-416b-a363-5dca533a8f88)
- [FDA Inspection 683172 - 2010-09-22](https://www.keypedia.com/records/fda_inspections/department-af-81st-med-groupsgqc-keesler-afb-mc-blood-bank/12c0b5a2-b5f2-4785-9422-c9d02543dd6f)

Company: https://www.keypedia.com/companies/department-af-81st-med-groupsgqc-keesler-afb-mc-blood-bank/b44a46ea-a77f-4854-a326-43a563251de9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d